ImpactLife lifts deferral for potential exposure to Mad Cow Disease

ImpactLife will reinstate more than 5000 potential donors who were previously deferred from blood donation under donor eligibility guidance that was recently updated by the U.S. Food and Drug Administration. Following new guidance issued by the FDA in July, ImpactLife has removed indefinite deferrals for 5126 potential donors who were previously deferred from blood donation due to travel or residence in the United Kingdom, France, or Ireland. The deferral was related to a theoretical risk of transmitting Cruetzfeldt-Jakob Disease (also known as Mad Cow Disease) to blood transfusion recipients. FDA has determined this is no longer a concern for donors who have previously lived in the United Kingdom and other European countries. READ MORE